Schroder Investment Management Group reduced its position in Teladoc Inc (NYSE:TDOC) by 2.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 360,214 shares of the health services provider’s stock after selling 10,682 shares during the quarter. Schroder Investment Management Group owned about 0.63% of Teladoc worth $11,761,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. ETF Managers Group LLC acquired a new position in shares of Teladoc in the second quarter worth about $104,000. Bank of Montreal Can raised its position in shares of Teladoc by 214.2% during the 2nd quarter. Bank of Montreal Can now owns 3,516 shares of the health services provider’s stock worth $123,000 after purchasing an additional 2,397 shares during the last quarter. Pacad Investment Ltd. acquired a new position in shares of Teladoc during the 2nd quarter worth about $135,000. Fred Alger Management Inc. acquired a new position in shares of Teladoc during the 2nd quarter worth about $139,000. Finally, Legal & General Group Plc raised its position in shares of Teladoc by 66.3% during the 1st quarter. Legal & General Group Plc now owns 6,137 shares of the health services provider’s stock worth $154,000 after purchasing an additional 2,446 shares during the last quarter.
Shares of Teladoc Inc (TDOC) traded up $1.95 on Friday, hitting $35.95. 1,522,462 shares of the stock were exchanged, compared to its average volume of 1,290,000. Teladoc Inc has a fifty-two week low of $15.65 and a fifty-two week high of $37.90. The company has a current ratio of 5.08, a quick ratio of 5.08 and a debt-to-equity ratio of 0.83.
Teladoc (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, November 1st. The health services provider reported ($0.55) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.30) by ($0.25). The firm had revenue of $68.70 million during the quarter, compared to analyst estimates of $67.53 million. Teladoc had a negative net margin of 39.61% and a negative return on equity of 21.59%. Teladoc’s revenue for the quarter was up 112.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.33) earnings per share. equities analysts expect that Teladoc Inc will post -1.56 EPS for the current year.
Several research analysts recently weighed in on TDOC shares. Oppenheimer upped their price target on shares of Teladoc from $40.00 to $45.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 21st. Canaccord Genuity set a $42.00 price objective on shares of Teladoc and gave the company a “buy” rating in a research note on Friday, November 17th. SunTrust Banks reaffirmed a “buy” rating and set a $40.00 price objective on shares of Teladoc in a research note on Friday, November 3rd. Cowen reaffirmed an “outperform” rating and set a $39.00 price objective on shares of Teladoc in a research note on Saturday, September 30th. Finally, BidaskClub cut shares of Teladoc from a “hold” rating to a “sell” rating in a research note on Wednesday, November 15th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $39.15.
In related news, VP Mark Hirschhorn sold 25,000 shares of the firm’s stock in a transaction dated Friday, September 22nd. The shares were sold at an average price of $31.93, for a total value of $798,250.00. Following the completion of the sale, the vice president now owns 64,987 shares in the company, valued at $2,075,034.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jason N. Gorevic sold 20,000 shares of the firm’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $33.47, for a total transaction of $669,400.00. The disclosure for this sale can be found here. Insiders have sold a total of 265,000 shares of company stock worth $8,697,400 over the last three months. 4.47% of the stock is currently owned by insiders.
Teladoc Company Profile
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.